EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Technical review by the ESPGHAN Special Interest Group on Gut Microbiota and Modifications on the health outcomes of infant formula supplemented with synbiotic

Silvia Salvatore, Ener Cagri Dinleyici, Hania Szajewska, Roberto Berni Canani, Pedro Gutierrez-Castrellón, Iva Hojsak, Flavia Indrio, Walter Mihatsch, Rok Orel, Johannes B van Goudoever, Yvan Vandenplas, ESPGHAN Special Interest Group on Gut Microbiota and Modification

Journal of Pediatric Gastroenterology and Nutrition · 2026-01 · 82 (1) · 213-224

DOI: 10.1002/jpn3.70031 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Pediatric Gastroenterology and Nutrition, online erschienen am 21.03.2025. Verfasst von Silvia Salvatore und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine and Technological Innovation, Pediatrics, University of Insubria, Varese, Italy. Hauptthemen laut MEDLINE: Synbiotics, Infant Formula, Gastrointestinal Microbiome, Dietary Supplements. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: None.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This technical review—one of five developed by the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Special Interest Group on Gut Microbiota and Modifications (SIG‐GMM)—supports the preparation of a position paper on the use of biotic‐ and synbiotic‐supplemented infant formulas. This paper also presents the statements made by the SIG‐GMM after performing a technical review to evaluate the clinical effects of synbiotic‐supplemented infant formulas in healthy full‐term infants (0–12 months), as emerged from studies published before 2024. The review focused on the following clinical outcomes (if available): anthropometric measurements, safety, tolerability, stool frequency and consistency, infantile colic or crying, gastrointestinal symptoms, infections and antibiotic use, and allergic disorders. Following the review, all members of the SIG anonymously voted on each statement, scoring them between 0 and 9. A statement was accepted when ≥75% of the members scored >6. The technical review identified 16 randomized controlled trials that evaluated the clinical effects of synbiotic‐supplemented infant formula in healthy full‐term infants. The studies varied in terms of synbiotic composition, study design, intervention duration, and outcomes. Formulas supplemented with synbiotics studied so far were well tolerated and showed no significant difference compared to the non‐supplemented formulas in growth parameters, gastrointestinal symptoms, stool characteristics, or safety. This technical review serves as the background for formulating recommendations on the use of synbiotic‐supplemented infant formula in healthy infants studied so far.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SynbioticsInfant FormulaGastrointestinal MicrobiomeDietary SupplementsHumansInfantInfant, NewbornInfant Nutritional Physiological PhenomenaRandomized Controlled Trials as Topic

Stichwörter der Autor:innen

anthropometrybioticsbreastfeedingformula feedingmicrobiomenutrition

Autor:innen und Institutionen

  • Department of Medicine and Technological Innovation, Pediatrics, University of Insubria, Varese, Italy.
  • Department of Pediatrics, Eskisehir Osmangazi University Faculty of Medicine, Eskisehir, Turkey.
  • Department of Paediatrics, The Medical University of Warsaw, Warsaw, Poland.
  • Department of Translational Medical Science and Immuno Nutrition Lab of the CEINGE Advanced Biotechnologies Research Center and Task Force on Microbiome Studies and European Laboratory for the Investigation of Food-Indu…
  • Universidad Juarez del Estado de Durango & International Scientific Council for Probiotics S.C, Mexico City, Mexico.
  • Children's Hospital Zagreb, University of Zagreb Medical School, Zagreb, Croatia.

Förderung

  • None

Zitieren

APA

Salvatore, S., Dinleyici, E. C., Szajewska, H., Canani, R. B., Gutierrez-Castrellón, P., Hojsak, I., Indrio, F., Mihatsch, W., Orel, R., van Goudoever, J. B., Vandenplas, Y., & ESPGHAN Special Interest Group on Gut Microbiota and Modification (2026). Technical review by the ESPGHAN Special Interest Group on Gut Microbiota and Modifications on the health outcomes of infant formula supplemented with synbiotic. Journal of Pediatric Gastroenterology and Nutrition, 82(1), 213-224. https://doi.org/10.1002/jpn3.70031

Vancouver

Salvatore S, Dinleyici EC, Szajewska H, Canani RB, Gutierrez-Castrellón P, Hojsak I, et al. Technical review by the ESPGHAN Special Interest Group on Gut Microbiota and Modifications on the health outcomes of infant formula supplemented with synbiotic. Journal of Pediatric Gastroenterology and Nutrition. 2026;82(1):213-224. doi:10.1002/jpn3.70031

BibTeX
@article{Salvatore2026,
  author = {Salvatore, Silvia and Dinleyici, Ener Cagri and Szajewska, Hania and Canani, Roberto Berni and Gutierrez-Castrellón, Pedro and Hojsak, Iva and Indrio, Flavia and Mihatsch, Walter and Orel, Rok and van Goudoever, Johannes B and Vandenplas, Yvan and ESPGHAN Special Interest Group on Gut Microbiota and Modification, ESPGHAN Special Interest Group on Gut Microbiota and Modification},
  title = {Technical review by the ESPGHAN Special Interest Group on Gut Microbiota and Modifications on the health outcomes of infant formula supplemented with synbiotic},
  journal = {Journal of Pediatric Gastroenterology and Nutrition},
  year = {2026},
  volume = {82},
  number = {1},
  pages = {213--224},
  doi = {10.1002/jpn3.70031}
}
Kostenlos starten →